Quantum-Si incorporated (QSIAW) Aandelenanalyse

Bedrijfsoverzicht

Quantum-Si Incorporated is a life sciences entity focused on developing a proprietary, universal, and single-molecule detection platform specifically applied to the field of proteomics. This technological focus enables next-generation protein sequencing (NGPS), a critical capability for advancing protein analysis at the amino acid level. The company operates with a workforce of 145 employees, reflecting its current operational scale within the specialized biotechnology landscape. Despite the specialized nature of its single-molecule detection instruments, including the Platinum and Platinum Pro NGPS platforms, the firm reports a market capitalization that is not publicly disclosed alongside a trailing twelve-month revenue of $2.44 million. The combination of a defined employee base and a market capitalization that is unavailable indicates a company that is likely in a development or early commercialization phase where traditional valuation metrics based on total market size may not yet be fully established or reported.

Financiële gezondheid

The company generated $2.44 million in revenue over the trailing twelve months, yet reported a net income loss of $101,339,000, revealing a significant disconnect between top-line generation and bottom-line profitability. This substantial gap between revenue and net income highlights an aggressive cost structure or heavy investment in research and development that exceeds current earnings capabilities. EBITDA stands at -$92,594,000, further confirming that operating expenses are significantly outpacing operational revenues. Free cash flow is negative at -$45,797,000, indicating that the company is burning cash and lacks the immediate financial flexibility to fund operations without external capital injections. The gross margin sits at 47.3%, suggesting that the cost of goods sold for these high-tech instruments is managed reasonably well relative to sales prices. In contrast, the operating margin is negative 4677.2% and the profit margin is 0.0%, metrics that indicate extreme operational inefficiency or substantial non-operating losses impacting the bottom line. The company holds $162.91 million in cash against total debt of $4.17 million, creating a scenario where liquidity significantly outweighs obligations. The debt-to-equity ratio of 1.89 suggests a leveraged balance sheet structure, yet the massive cash reserve provides a substantial buffer against this debt load. Current ratio stands at 7.64, a figure that indicates robust short-term liquidity and a strong ability to meet immediate financial obligations with current assets. Return on Equity is -46.5% and Return on Assets is -24.6%, metrics that reveal that management has not yet generated positive returns on the capital deployed by shareholders or the asset base.

Waarderingsbeoordeling

Trailing P/E and forward P/E ratios are not available due to the company's lack of earnings, which precludes standard earnings-based valuation multiples. The price-to-book ratio is 0.11, a figure that indicates the company is trading at a deep discount relative to its book value, suggesting the market values its assets at a fraction of their accounting value. Price-to-sales and EV/EBITDA ratios are unavailable, preventing the use of revenue or enterprise value-based metrics to assess the company's relative cheapness or expensiveness. The stock has traded between a 52-week high of $0.11 and a 52-week low of $0.10, meaning the current trading environment is extremely compressed within a one-cent range. The beta value is 3.09, a metric that indicates the stock's price volatility is significantly higher than the broader market, moving with three times the intensity of the S&P 500. This high beta suggests that price movements are amplified, potentially offering high-risk/high-reward characteristics for traders willing to accept extreme fluctuations in share price.

Growth & Income

Revenue growth year-over-year stands at -62.2%, while earnings growth is not applicable due to the reported losses, indicating that the business is currently shrinking rather than expanding. Since earnings are negative, the comparison of growth rates between earnings and revenue is not feasible, but the negative revenue growth signals a contraction in sales or a significant shift in market dynamics. As the company does not pay dividends, indicated by an unavailable dividend yield and payout ratio, it retains all earnings to reinvest into its proprietary detection platform and research initiatives. Consequently, the overall growth and income profile is characterized by a lack of income generation and a contraction in revenue, relying entirely on the depletion of its cash reserves to fund future development and operational needs.